Literature DB >> 28881293

The anti-tumor effect of aspirin: What we know and what we expect.

Ji Ma1, Zhonglin Cai2, Hongliang Wei3, Xinlan Liu4, Qingli Zhao5, Tao Zhang6.   

Abstract

Aspirin has been widely used as an antipyretic analgesic drug. More and more evidences have shown that aspirin may be play some role on anti-tumor. In this article, we reviewed the research history of aspirin in the treatment and prevention of cancer. Many epidemiological and clinical studies have shown that aspirin can reduce the risk of a variety of malignant tumors and reduce cancer mortality. In addition, we discuss the specific mechanisms of aspirin in the anti-tumor effects. It has been found that aspirin mainly depends on the COX pathway and non-COX pathway to inhibit tumor cell growth and to curb tumor development. In this article, clinical studies and anti-tumor mechanism studies published in recent years are reviewed.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Aspirin; Cancer; Clinical research; Molecular mechanisms

Mesh:

Substances:

Year:  2017        PMID: 28881293     DOI: 10.1016/j.biopha.2017.08.085

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  Indirect study of the effect of α-tocopherol and acetylsalicylic acid on the mineral composition of bone tissue in the offspring of female rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: long-term observations.

Authors:  Maciej Dobrzynski; Piotr Kuropka; Malgorzata Tarnowska; Krzysztof Dudek; Marzena Styczynska; Anna Leskow; Sara Targonska; Rafal J Wiglusz
Journal:  RSC Adv       Date:  2019-03-11       Impact factor: 4.036

2.  Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer.

Authors:  Ji Ma; Zhenhai Fan; Qiulin Tang; Hongwei Xia; Tao Zhang; Feng Bi
Journal:  Cell Death Dis       Date:  2020-07-13       Impact factor: 8.469

3.  Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation.

Authors:  Giacomo Pozzoli; Giovanna Petrucci; Pierluigi Navarra; Hany E Marei; Carlo Cenciarelli
Journal:  J Cell Mol Med       Date:  2019-08-20       Impact factor: 5.310

4.  Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas.

Authors:  Kinga Németh; Nikolette Szücs; Sándor Czirják; Lilla Reiniger; Borbála Szabó; Gábor Barna; Katalin Karászi; Péter Igaz; Vladimir Zivkovic; Márta Korbonits; Attila Patócs; Henriett Butz
Journal:  Oncotarget       Date:  2018-06-26

5.  Aspirin sensitizes osimertinib-resistant NSCLC cells in vitro and in vivo via Bim-dependent apoptosis induction.

Authors:  Rui Han; Shuai Hao; Conghua Lu; Chong Zhang; Caiyu Lin; Li Li; Yubo Wang; Chen Hu; Yong He
Journal:  Mol Oncol       Date:  2020-05-05       Impact factor: 6.603

6.  Aspirin metabolites 2,3‑DHBA and 2,5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention.

Authors:  Ranjini Sankaranarayanan; Chaitanya K Valiveti; Rakesh Dachineni; D Ramesh Kumar; Tana Lick; G Jayarama Bhat
Journal:  Mol Med Rep       Date:  2019-11-18       Impact factor: 2.952

Review 7.  The updated landscape of tumor microenvironment and drug repurposing.

Authors:  Ming-Zhu Jin; Wei-Lin Jin
Journal:  Signal Transduct Target Ther       Date:  2020-08-25

8.  Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer.

Authors:  Shang-Jui Wang; Karishma Khullar; Sinae Kim; Nikhil Yegya-Raman; Jyoti Malhotra; Roman Groisberg; Samuel H Crayton; Ann W Silk; John L Nosher; Michael A Gentile; Janice M Mehnert; Salma K Jabbour
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

Review 9.  The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis.

Authors:  Raghav Chandra; John D Karalis; Charles Liu; Gilbert Z Murimwa; Josiah Voth Park; Christopher A Heid; Scott I Reznik; Emina Huang; John D Minna; Rolf A Brekken
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

10.  Aspirin associated with a decreased incidence of uterine cancer: A retrospective population-based cohort study.

Authors:  Pei-Chen Li; Fung-Chang Sung; Yu-Cih Yang; Weishan Chen; Jen-Hung Wang; Shinn-Zong Lin; Dah-Ching Ding
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.